Compound class:
Antibody
Comment: LY2928057 is an investigational anti-ferroportin monoclonal being developed as a treatment for anemia. A search of patents reveals WO2010065496 A1 as Eli Lilly's application covering the development and use of anti-ferroportin 1 monoclonal antibodies [1]. The HGNC approved gene symbol for ferroportin 1 is SLC40A1.
|
References |
1. Leung DDM, Luan P, Manetta JV, Tang Y, Witcher DR,. (2010)
Anti-ferroportin 1 monoclonal antibodies and uses thereof. Patent number: WO2010065496 A1. Assignee: Eli Lilly And Company.. Priority date: 05/12/2008. Publication date: 10/06/2010. |